Nuclear Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Nuclear Imaging and Devices Market is Segmented by Product (Equipment and Radioisotope (SPECT Radioisotopes (Technetium-99m (TC-99m), Thallium-201 (TI-201), Gallium (Ga-67), Iodine (I-123), and Other SPECT Radioisotopes) and PET Radioisotopes (Fluorine-18 (F-18), Rubidium-82 (RB-82), and Other PET Radioisotopes))), Application (SPECT Applications (Cardiology, Neurology, Thyroid, and Other SPECT Applications) and PET Applications (Oncology, Cardiology, Neurology, and Other PET Applications)), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Nuclear Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Nuclear Imaging Market Size

Nuclear Imaging Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 16.53 Billion
Market Size (2030) USD 23.88 Billion
CAGR (2025 - 2030) 7.63 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Nuclear Imaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Nuclear Imaging Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Nuclear Imaging Market Analysis

The Nuclear Imaging Market size is estimated at USD 16.53 billion in 2025, and is expected to reach USD 23.88 billion by 2030, at a CAGR of 7.63% during the forecast period (2025-2030).

The Nuclear Imaging Market was moderately impacted due to the pandemic. The operation of reactors has been largely classified as an essential service, given its criticality. Therefore, Nuclear Reactors were not shut down during the lockdown. For instance, under Section 71 of the Labour Act 66 of 1995 in South Africa, its SAFARI-1 Reactor remained operational during the lockdown enforced in the country post-March 2020.

However, according to an article published in Seminar in Nuclear Medicine in June 2021, the number of Nuclear Studies, Nuclear Cardiac Imaging, and Oncology Positron Emission Tomography/Computed Tomography decreased in March and April 2020 due to the rise of COVID-19 cases and deaths as reported by the Centers for Disease Control and Prevention (CDC). The study further stated that procedures increased from June 2020 to February 2021 as COVID-19 cases declined. Thus, COVID-19 has slightly impacted the Nuclear Imaging Market with delays in clinical studies, postponement of various surgeries and imaging procedures, an increase in Teleradiology, and several staff-related limitations. However, since the lockdown restrictions were lifted, the industry has been recovering well.

Over the last two years, the market recovery has been led by the high prevalence of chronic diseases. Patients' hospital visits for imaging diagnosis increased as the restrictions were relaxed, and so the Medical Imaging Industry saw a major surge in diagnostics and treatment. This is expected to promote the market's growth in the next few years.

Certain factors that are propelling the growth of the market include technological advancements, increasing diagnostic applications in various diseases, such as cancer and cardiovascular diseases, government support, and a shift from standalone imaging to Hybrid Imaging Systems modalities. For instance, according to the Breast Cancer Factsheet Now 2021, around 55,000 women and 370 men in the United Kingdom are diagnosed with breast cancer every year. Breast cancer has claimed the lives of an estimated 600,000 people in the United Kingdom. This figure is expected to climb to 1.2 million by 2030. Moreover, the growing prevalence of heart diseases is expected to propel the growth of the market. As stated by the American Heart Association 2021 Journal, it is estimated that by 2035, more than 130 million adults in the United States will have some type of heart disease. Thus, the growing prevalence of chronic diseases such as cancer and cardiac diseases is expected to increase demand for early and effective diagnosis, thereby boosting the growth of the Nuclear Imaging Market over the forecast period.

Technological advancements in the Medical Nuclear Imaging System Market have always been challenging to practitioners in terms of how best to optimize them in patient care. Over the past few years, scientists, researchers, and technologists have been able to bring Hybrid Imaging Systems into clinical practice, in which two or even more standalone diagnostic imaging modalities are combined. Some of those multimodality imaging systems include PET/CT, SPECT/CT, PET/MRI, and PET/SPECT/CT. For instance, in October 2022, Spectrum Dynamics announced its newest development in digital Nuclear Medicine Imaging capability to image high-energy isotopes using solid-state detector technology in a 3600-CZT-based, wide-bore SPECT/CT configuration. This functionality is available in the new VERITON-CT 400 Series Digital SPECT/CT scanners, enabling total body, brain, heart, and other imaging applications. With such advances in Nuclear Imaging, the market studied is expected to grow significantly over the forecast period.

The key players are working on many strategic initiatives such as mergers, acquisitions, collaborations, partnerships, and product launches. For instance, in January 2021, Koninklijke Philips NV and Rennes University Hospital signed a five-year innovation and technology partnership to support PET diagnostics, interventional imaging, patient monitoring, and management, among other things. Additionally, in March 2021, GE Healthcare launched StarGuide in the United Kingdom, a next-generation SPECT/CT system that uses the latest digital technologies to help clinicians improve patient outcomes in bone procedures, cardiology, neurology, oncology, and other specialties.

According to the factors mentioned above, such as the growing prevalence of chronic diseases and technological advances in Nuclear Medicine Imaging, the market studied is anticipated to witness growth over the forecast period. However, regulatory issues and a lack of reimbursement may restrain the market's growth.

Nuclear Imaging Industry Overview

The global Nuclear Imaging Equipment Market is highly competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. Companies like Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, General Electric Company (GE Healthcare), and Siemens Healthineers hold a substantial share of the market. Leading market players are opting for geographic expansion, strategic collaborations, and partnerships through mergers and acquisitions in emerging and economically favorable regions.

Nuclear Imaging Market Leaders

  1. Bracco Imaging SpA

  2. Cardinal Health Inc.

  3. Koninklijke Philips NV

  4. Siemens Healthineers

  5. General Electric Company (GE Healthcare)

  6. *Disclaimer: Major Players sorted in no particular order
Picture1.png
Need More Details on Market Players and Competiters?
Download PDF

Nuclear Imaging Market News

  • October 2022: United Imaging Healthcare announced the launch of total-body PET/CT, uEXPLORER, with a 194 cm axial PET field of view (FOV) that allows the complete body to be scanned in a one-bed position. The ultra-high-resolution digital PET/CT system provides total-body dynamic scanning, allowing ultra-low patient dose, and delivering ultra-high picture resolution, thereby revolutionizing whole-body PET/CT imaging.
  • October 2022: GE Healthcare introduced the Omni Legend positron emission tomography/ computed tomography (PET/CT) platform at the 35th Annual Congress of the European Association of Nuclear Medicine (EANM) in Barcelona, Spain.

Nuclear Imaging Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Cancer and Cardiac Disorders
    • 4.2.2 Increase in Technological Advancements
    • 4.2.3 Growth in Applications of Nuclear Medicine and Imaging
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Issues
    • 4.3.2 Lack of Reimbursement
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Equipment
    • 5.1.2 Radioisotope
    • 5.1.2.1 SPECT Radioisotopes
    • 5.1.2.1.1 Technetium-99m (TC-99m)
    • 5.1.2.1.2 Thallium-201 (TI-201)
    • 5.1.2.1.3 Gallium (Ga-67)
    • 5.1.2.1.4 Iodine (I-123)
    • 5.1.2.1.5 Other SPECT Radioisotopes
    • 5.1.2.2 PET Radioisotopes
    • 5.1.2.2.1 Fluorine-18 (F-18)
    • 5.1.2.2.2 Rubidium-82 (RB-82)
    • 5.1.2.2.3 Other PET Radioisotopes
  • 5.2 By Application
    • 5.2.1 SPECT Applications
    • 5.2.1.1 Cardiology
    • 5.2.1.2 Neurology
    • 5.2.1.3 Thyroid
    • 5.2.1.4 Other SPECT Applications
    • 5.2.2 PET Applications
    • 5.2.2.1 Oncology
    • 5.2.2.2 Cardiology
    • 5.2.2.3 Neurology
    • 5.2.2.4 Other PET Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bracco Imaging SpA
    • 6.1.2 Cardinal Health Inc.
    • 6.1.3 General Electric Company (GE Healthcare)
    • 6.1.4 Koninklijke Philips NV
    • 6.1.5 Siemens Healthineers
    • 6.1.6 Curium
    • 6.1.7 CMR Naviscan (Gamma Medica Inc.)
    • 6.1.8 Nordion (Canada) Inc.
    • 6.1.9 NTP Radioisotopes SOC
    • 6.1.10 Canon Medical Systems Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Nuclear Imaging Industry Segmentation

As per the scope of the report, nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. They are small substances that contain a radioactive substance that is used in the treatment of cancer and cardiac and neurological disorders. 

The global nuclear imaging market is expected to register a CAGR of 7.63% during the forecast period. The global nuclear imaging market is segmented by product (equipment and radioisotope (SPECT radioisotopes (Technetium-99m (TC-99m), Thallium-201 (TI-201), Gallium (Ga-67), Iodine (I-123), and other SPECT radioisotopes) and PET radioisotopes (Fluorine-18 (F-18), Rubidium-82 (RB-82), and other PET radioisotopes))), application (SPECT applications (cardiology, neurology, thyroid, and other SPECT applications) and PET applications (oncology, cardiology, neurology, and other PET applications)), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.

By Product Equipment
Radioisotope SPECT Radioisotopes Technetium-99m (TC-99m)
Thallium-201 (TI-201)
Gallium (Ga-67)
Iodine (I-123)
Other SPECT Radioisotopes
PET Radioisotopes Fluorine-18 (F-18)
Rubidium-82 (RB-82)
Other PET Radioisotopes
By Application SPECT Applications Cardiology
Neurology
Thyroid
Other SPECT Applications
PET Applications Oncology
Cardiology
Neurology
Other PET Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Nuclear Imaging Market Research FAQs

How big is the Nuclear Imaging Market?

The Nuclear Imaging Market size is expected to reach USD 16.53 billion in 2025 and grow at a CAGR of 7.63% to reach USD 23.88 billion by 2030.

What is the current Nuclear Imaging Market size?

In 2025, the Nuclear Imaging Market size is expected to reach USD 16.53 billion.

Who are the key players in Nuclear Imaging Market?

Bracco Imaging SpA, Cardinal Health Inc., Koninklijke Philips NV, Siemens Healthineers and General Electric Company (GE Healthcare) are the major companies operating in the Nuclear Imaging Market.

Which is the fastest growing region in Nuclear Imaging Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Nuclear Imaging Market?

In 2025, the North America accounts for the largest market share in Nuclear Imaging Market.

What years does this Nuclear Imaging Market cover, and what was the market size in 2024?

In 2024, the Nuclear Imaging Market size was estimated at USD 15.27 billion. The report covers the Nuclear Imaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Nuclear Imaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Nuclear Imaging Industry Report

The Nuclear Imaging and Devices Market is segmented by product, application, and geography. The market size is determined by equipment and radioisotopes, which include SPECT and PET radioisotopes. SPECT radioisotopes consist of Technetium-99m, Thallium-201, Gallium-67, Iodine-123, and others, while PET radioisotopes include Fluorine-18, Rubidium-82, and others.

The market analysis reveals that the SPECT applications cover cardiology, neurology, thyroid, and other areas, whereas PET applications include oncology, cardiology, neurology, and other fields. The market report provides insights into market share across various regions, including North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

Global market trends indicate a steady growth rate, with industry analysis highlighting significant developments. The report also includes a market forecast, offering an industry overview and market outlook up to 2029. The industry reports and market research emphasize the importance of market leaders and their influence on market growth.

Industry information and market data are critical for understanding the market segmentation and market value. The industry research and market predictions provide a comprehensive market review, focusing on market trends and industry statistics. The market forecast and industry outlook are essential for identifying future opportunities and challenges.

The report example and report PDF are available for those interested in detailed industry analysis and industry sales. Research companies can benefit from the insights provided in the report, which offers a thorough market overview and market segmentation.

In summary, the Nuclear Imaging and Devices Market report is a valuable resource for understanding market dynamics, growth rate, and industry trends. It provides an in-depth market review, highlighting key market data and market predictions. The report is essential for industry research, offering a detailed market overview and market outlook.